Akoya Biosciences (AKYA) Revenue & Revenue Breakdown
Akoya Biosciences Revenue Highlights
Latest Revenue (Y)
$96.63M
Latest Revenue (Q)
$23.16M
Main Segment (Y)
Product
Main Geography (Y)
North America
Akoya Biosciences Revenue by Period
Akoya Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $96.63M | 29.09% |
| 2022-12-31 | $74.86M | 36.31% |
| 2021-12-31 | $54.92M | 29.39% |
| 2020-12-31 | $42.44M | 0.49% |
| 2019-12-31 | $42.24M | - |
Akoya Biosciences generated $96.63M in revenue during NA 2023, up 29.09% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Akoya Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $23.16M | 26.23% |
| 2024-03-31 | $18.35M | -30.72% |
| 2023-12-31 | $26.49M | 5.04% |
| 2023-09-30 | $25.21M | 7.20% |
| 2023-06-30 | $23.52M | 9.86% |
| 2023-03-31 | $21.41M | 0.90% |
| 2022-12-31 | $21.22M | 12.56% |
| 2022-09-30 | $18.85M | 5.35% |
| 2022-06-30 | $17.89M | 5.92% |
| 2022-03-31 | $16.89M | 4.56% |
| 2021-12-31 | $16.16M | 19.90% |
| 2021-09-30 | $13.48M | 3.10% |
| 2021-06-30 | $13.07M | 7.03% |
| 2021-03-31 | $12.21M | -5.39% |
| 2020-12-31 | $12.91M | 29.68% |
| 2020-09-30 | $9.95M | 16.29% |
| 2020-06-30 | $8.56M | -22.33% |
| 2020-03-31 | $11.02M | - |
Akoya Biosciences generated $23.16M in revenue during Q2 2024, up 26.23% compared to the previous quarter, and up 108.19% compared to the same period a year ago.
Akoya Biosciences Revenue Breakdown
Akoya Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Product | $67.41M | $57.65M | $44.48M |
| Consumables | $24.13M | $18.38M | $14.30M |
| Instruments | $42.09M | $38.63M | $28.69M |
| Service And Other | $18.93M | - | - |
| Standalone software products | $1.18M | $636.00K | $1.49M |
| Service and other | $29.22M | $17.21M | $10.44M |
Akoya Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (36.84%), Instruments (23.01%), Service and other (15.97%), Consumables (13.19%), Service And Other (10.35%), and Standalone software products (0.65%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Instruments | $4.87M | $21.21M | $11.28M | $9.61M | $11.14M | $9.51M | $9.46M | $8.52M | $8.50M | $7.10M | $6.26M | $6.84M |
| Standalone software products | $270.00K | $924.00K | $52.00K | $205.00K | $39.00K | $200.00K | $203.00K | $194.00K | $409.00K | - | - | - |
| Product | $12.14M | $34.74M | $17.15M | $15.52M | $15.71M | $14.44M | $14.16M | $13.34M | $12.92M | $10.87M | $10.72M | $9.96M |
| Service and other | $6.21M | $16.96M | $6.37M | $5.89M | $5.51M | $4.41M | $3.73M | $3.55M | $3.24M | - | - | - |
| Consumables | $7.00M | $12.60M | $5.82M | $5.71M | $4.53M | $4.72M | $4.50M | $4.63M | $4.01M | $3.43M | $4.31M | $2.54M |
| Service And Other | $3.38M | - | - | - | - | - | - | - | - | - | - | - |
| Standalone Software Products | - | - | - | - | - | - | - | - | - | $345.00K | $151.00K | $582.00K |
| Service | - | - | - | - | - | - | - | - | - | $2.60M | $2.35M | $2.25M |
Akoya Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (35.84%), Consumables (20.67%), Service and other (18.33%), Instruments (14.37%), Service And Other (9.99%), and Standalone software products (0.80%).
Akoya Biosciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| APAC | $16.55M | $15.06M | $12.53M |
| North America | $58.28M | $42.05M | $28.03M |
| EMEA | $21.80M | $17.75M | $14.36M |
Akoya Biosciences's latest annual revenue breakdown by geography, as of Dec 23: North America (60.31%), EMEA (22.56%), and APAC (17.13%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APAC | $3.27M | $8.06M | $4.11M | $4.39M | $3.47M | $3.81M | $4.27M | $3.51M | $3.00M | - | - | - |
| North America | $10.12M | $32.62M | $13.81M | $11.85M | $12.32M | $10.92M | $9.48M | $9.32M | $9.02M | $7.39M | $6.40M | $5.21M |
| EMEA | $4.96M | $11.02M | $5.60M | $5.17M | $5.43M | $4.12M | $4.14M | $4.06M | $4.13M | - | - | - |
| Asia Pacific | - | - | - | - | - | - | - | - | - | $2.83M | $3.01M | $3.69M |
| E M E A | - | - | - | - | - | - | - | - | - | $3.25M | $3.66M | $3.31M |
Akoya Biosciences's latest quarterly revenue breakdown by geography, as of Mar 24: North America (55.17%), EMEA (27.01%), and APAC (17.82%).
Akoya Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| COO | Cooper Companies | $3.59B | $1.00B |
| ATR | AptarGroup | $3.49B | $910.06M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| ATRC | AtriCure | $399.25M | $116.27M |
| ANGO | AngioDynamics | $303.91M | $75.18M |
| LMAT | LeMaitre Vascular | $193.48M | $55.85M |
| AKYA | Akoya Biosciences | $96.63M | $23.16M |
| PDEX | Pro-Dex | $53.84M | $14.29M |
| UTMD | Utah Medical Products | $50.22M | $10.40M |
| ATRI | Atrion | - | $48.77M |
AKYA Revenue FAQ
What is Akoya Biosciences’s yearly revenue?
Akoya Biosciences's yearly revenue for 2023 was $96.63M, representing an increase of 29.09% compared to 2022. The company's yearly revenue for 2022 was $74.86M, representing an increase of 36.31% compared to 2021. AKYA's yearly revenue for 2021 was $54.92M, representing an increase of 29.39% compared to 2020.
What is Akoya Biosciences’s quarterly revenue?
Akoya Biosciences's quarterly revenue for Q2 2024 was $23.16M, a 26.23% increase from the previous quarter (Q1 2024), and a -1.52% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $18.35M, a -30.72% decrease from the previous quarter (Q4 2023), and a -14.29% decrease year-over-year (Q1 2023). AKYA's quarterly revenue for Q4 2023 was $26.49M, a 5.04% increase from the previous quarter (Q3 2023), and a 24.83% increase year-over-year (Q4 2022).
What is Akoya Biosciences’s revenue growth rate?
Akoya Biosciences's revenue growth rate for the last 3 years (2021-2023) was 75.96%, and for the last 5 years (2019-2023) was 128.79%.
What are Akoya Biosciences’s revenue streams?
Akoya Biosciences's revenue streams in c 23 are Product, Consumables, Instruments, Service And Other, Standalone software products, and Service and other. Product generated $67.41M in revenue, accounting 36.84% of the company's total revenue, up 16.93% year-over-year. Consumables generated $24.13M in revenue, accounting 13.19% of the company's total revenue, up 31.31% year-over-year. Instruments generated $42.1M in revenue, accounting 23.01% of the company's total revenue, up 8.96% year-over-year. Service And Other generated $18.93M in revenue, accounting 10.35% of the company's total revenue Standalone software products generated $1.18M in revenue, accounting 0.65% of the company's total revenue, up 85.69% year-over-year. Service and other generated $29.22M in revenue, accounting 15.97% of the company's total revenue, up 69.81% year-over-year.
What is Akoya Biosciences’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Akoya Biosciences was Product. This segment made a revenue of $67.41M, representing 36.84% of the company's total revenue.